Published in Pathol Biol (Paris) on December 01, 1978
Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol (1979) 1.12
Immunogenicity and the vascular risk of oral contraceptives. Br Heart J (1985) 0.77
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet (2000) 2.63
Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci U S A (1998) 2.15
10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet (1996) 1.99
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Support Care Cancer (2012) 1.45
[Transfusional strategy in neurosurgery: preoperative hemodilution by erythrocytapheresis]. Ann Fr Anesth Reanim (1994) 1.39
Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet (2001) 1.37
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
Characterization of microsatellite markers in mandarin orange (Citrus reticulata Blanco). Mol Ecol Resour (2008) 1.21
[Hyperlipidemia caused by anti-beta-lipoprotein autoantibodies. A new pathological entity]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.21
Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol (1970) 1.15
Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol (1979) 1.12
Roles for mitochondrial and reverse mode Na+/Ca2+ exchange and the plasmalemma Ca2+ ATPase in post-tetanic potentiation at crayfish neuromuscular junctions. J Neurosci (2001) 1.07
Postabsorption neutralization of poliovirus. J Virol (1993) 1.05
Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care (2001) 1.04
Expression of the SOX10 gene during human development. FEBS Lett (1998) 1.04
Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG. Clin Exp Immunol (1976) 0.98
Autoimmune hyperlipidemia. Atherosclerosis (1977) 0.98
Creation of an antigenic site in poliovirus type 1 by assembly of 14 S subunits. Virology (1990) 0.94
Development of ISFET array-based microsystems for bioelectrochemical measurements of cell populations. Biosens Bioelectron (2001) 0.93
Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol (1982) 0.93
The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J Med Genet (2004) 0.91
[Use of a detergent for the purification of antilipoprotein antibodies]. Immunochemistry (1970) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol (2012) 0.89
Tobacco and other factors in the etiology of ischemic heart disease in man: results of a retrospective survey. J Chronic Dis (1966) 0.89
[A common specificity in serum alpha and beta-lipoproteins demonstrated by a myeloma auto-antibody. The Pg antigen]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.88
[Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies]. Ann Biol Clin (Paris) (1970) 0.88
Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa. Clin Exp Immunol (1980) 0.88
A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man. Eur J Clin Pharmacol (1975) 0.87
Whole chromosome 17 loss in ovarian cancer. Genes Chromosomes Cancer (1993) 0.87
[Myeloma anti-lipoprotein autoantibodies. Comparative study of 2 types anti-Lp P.G. IgA and anti-Lp A.S. IgG]. Ann Biol Clin (Paris) (1970) 0.86
A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes? J Med Genet (2001) 0.86
Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology (1999) 0.84
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium. Nat Genet (1999) 0.83
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
[Detection of pill-induced antiethinylestradiol antibodies (author's transl)]. Ann Biol Clin (Paris) (1981) 0.82
[Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity]. Sem Hop (1975) 0.82
Cholesterol synthesis by human fibroblasts in the presence of LDL and anti-LDL IgA. Biomedicine (1979) 0.82
Detection and composition of circulating immune complexes in oral contraceptive users. Biomedicine (1979) 0.82
A fully electronic sensor for the measurement of cDNA hybridization kinetics. Biosens Bioelectron (2006) 0.82
[Passive hemagglutination with chromium chloride. Its use without macromolecular dilution]. Pathol Biol (Paris) (1969) 0.81
[Experimental hyperlipemia induced by immunization in the rabbit]. Pathol Biol (1968) 0.81
[A myeloma gamma A-globulin with a specific anti-lipoprotein activity. The anti-Pg autoantibody]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.81
[Anti-heparin immunoglobulins, a factor of thrombosis, hyperlipemia and atherosclerosis]. Pathol Biol (Paris) (1974) 0.80
[A second type of myeloma antilipoprotein autoantibody: IgG anti-Lp A1]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.80
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
Antiestrogen antibodies, oral contraception and systemic lupus erythematosus. Clin Physiol Biochem (1989) 0.79
[Blood triglycerides in a professional group]. J Atheroscler Res (1967) 0.79
Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab (1998) 0.79
[Immunochemical study of the lipoprotein substance Pg (author's transl)]. Pathol Biol (Paris) (1977) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
Space and time-resolved gene expression experiments on cultured mammalian cells by a single-cell electroporation microarray. N Biotechnol (2008) 0.78
Plateletpheresis concentrates produced with the COMTEC cell separator: the French experience. Transfus Apher Sci (2001) 0.78
[Abnormal electroencephalography results and specific language impairment: towards a theoretical neurodevelopmental model?]. Encephale (2012) 0.78
[Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases]. Gastroenterol Clin Biol (1994) 0.78
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis (1977) 0.78
[Purification of serum alpha-1-lipoproteins]. Ann Biol Clin (Paris) (1970) 0.78
[Giant cell thromboangiitis in a patient taking an oral contraceptive (author's transl)]. Rev Neurol (Paris) (1980) 0.78
A new serum lipoprotein associated erythrocyte antigen which reacts with a monoclonal IgM. The stored human red blood cell SHRBC antigen. Vox Sang (1976) 0.78
In vitro interaction of LDL, anti-lipoprotein IgA and human fibroblasts. Biomedicine (1978) 0.78
[Method of purification of rabbit antibody against human beta lipoprotein starting with specific precipitates]. Immunochemistry (1969) 0.78
[The specific activity of the M proteins. "Towards a new criterion for the classification of the myelomas and macroglobulinemias"]. Rev Fr Etud Clin Biol (1967) 0.78
[Presence of a phospholipid in the Pg site that reveals IgA myelomatous antilipoprotein (anti-Pg) ]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.78
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
[Presence of an anti-beta-lipoprotein auto-antibody in the serum of a rabbit having a hyperlipidemia by immunization (hyperlipidemia by experimental auto-antibodies)]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.77
[Agglutination phenomenon of lipid particles. Its value in sero-immunology]. Pathol Biol (Paris) (1972) 0.77
Immunogenicity and the vascular risk of oral contraceptives. Br Heart J (1985) 0.77
[A method for the purification of serum beta-lipoproteins]. Ann Biol Clin (Paris) (1968) 0.77
[An anti-heparin immunoglobulin in a hyperlipidemic serum. (A new variety of auto-antibody hyperlipidemia)]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.77